Literature DB >> 23773347

Updating the French method for the causality assessment of adverse drug reactions.

Yannick Arimone1, Irène Bidault, Jean-Paul Dutertre, Marie Gérardin, Claire Guy, Françoise Haramburu, Dominique Hillaire-Buys, Carmine Meglio, Catherine Penfornis, Hélène Théophile, Marie-Blanche Valnet-Rabier.   

Abstract

The Imputability Working Group (CRI) updated the French drug reaction causality assessment method. This tripartite group is made up of staff from the French network of regional pharmacovigilance centres, pharmaceutical companies, and the French National Agency for the Safety of Medicines and Health Products (ANSM). After reviewing the strengths and weaknesses of the previous method, several ideas for improvement were proposed: a better-worded and more discriminating scale for certain chronological and semiological criteria, a larger scale for the intrinsic score (increased from 5 to 7 levels), a new bibliographical scale to differentiate between expected and unexpected adverse drug reactions, and a new informativeness scale.
© 2013 Société Française de Pharmacologie et de Thérapeutique.

Entities:  

Mesh:

Year:  2013        PMID: 23773347     DOI: 10.2515/therapie/2013016

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  10 in total

1.  Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.

Authors:  Bethsabée Garel; Saskia Ingen-Housz-Oro; Daniele Afriat; Catherine Prost-Squarcioni; Florence Tétart; Benoit Bensaid; Corina Bara Passot; Marie Beylot-Barry; Vincent Descamps; Sophie Duvert-Lehembre; Sabine Grootenboer-Mignot; Géraldine Jeudy; Angèle Soria; Marie Blanche Valnet-Rabier; Annick Barbaud; Frédéric Caux; Bénédicte Lebrun-Vignes
Journal:  Br J Clin Pharmacol       Date:  2019-01-04       Impact factor: 4.335

2.  Three case reports of involuntary muscular movements as adverse reactions to sacubitril/valsartan.

Authors:  Theodora Bejan-Angoulvant; Thibaud Genet; Laura Vrignaud; Denis Angoulvant; Laurent Fauchier
Journal:  Br J Clin Pharmacol       Date:  2018-03-06       Impact factor: 4.335

3.  Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database.

Authors:  Jean-Baptiste Bossard; Camille Ponté; Julie Dupouy; Maryse Lapeyre-Mestre; Emilie Jouanjus
Journal:  Clin Drug Investig       Date:  2016-09       Impact factor: 2.859

Review 4.  Psoriasis After Exposure to Angiotensin-Converting Enzyme Inhibitors: French Pharmacovigilance Data and Review of the Literature.

Authors:  Brahim Azzouz; Aurore Morel; Lukshe Kanagaratnam; Emmanuelle Herlem; Thierry Trenque
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

5.  Joint medicine-information and pharmacovigilance services could improve detection and communication about drug-safety problems.

Authors:  Jan Schjøtt; Jenny Bergman
Journal:  Drug Healthc Patient Saf       Date:  2014-07-01

6.  Re-exploring immune-related side effects of docetaxel in an observational study: Blood hypereosinophilia.

Authors:  Diaddin Hamdan; Christophe Leboeuf; Christine Le Foll; Guilhem Bousquet; Anne Janin
Journal:  Cancer Med       Date:  2019-03-10       Impact factor: 4.452

7.  Shortcomings of Administrative Data to Derive Preventive Strategies for Inhospital Drug-Induced Acute Kidney Failure-Insights from Patient Record Analysis.

Authors:  Stefanie Amelung; David Czock; Markus Thalheimer; Torsten Hoppe-Tichy; Walter E Haefeli; Hanna M Seidling
Journal:  J Clin Med       Date:  2022-07-23       Impact factor: 4.964

8.  Frequency, Characteristics, and Predictive Factors of Adverse Drug Events in an Adult Emergency Department according to Age: A Cross-Sectional Study.

Authors:  Laura Lohan; Grégory Marin; Marie Faucanie; Marion Laureau; Damien Perier; Véronique Pinzani; Isabelle Giraud; Maxime Villiet; Mustapha Sebbane; Ariane Sultan; Cyril Breuker
Journal:  J Clin Med       Date:  2022-09-27       Impact factor: 4.964

9.  The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.

Authors:  Emanuel Raschi; Elisabetta Poluzzi; Francesco Salvo; Ariola Koci; Marc Suling; Stefania Antoniazzi; Luisella Perina; Lorna Hazell; Ugo Moretti; Miriam Sturkenboom; Edeltraut Garbe; Antoine Pariente; Fabrizio De Ponti
Journal:  Drug Saf       Date:  2016-01       Impact factor: 5.606

10.  Serious Neurological Adverse Events of Ceftriaxone.

Authors:  Clémence Lacroix; Annie-Pierre Bera-Jonville; François Montastruc; Lionel Velly; Joëlle Micallef; Romain Guilhaumou
Journal:  Antibiotics (Basel)       Date:  2021-05-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.